1QA9

structure of a heterophilic adhesion complex between the human cd2 and cd58(lfa-3) counter-receptors

• Total interactions analyzed: 6
• Total true interactions: 3
• Strongest Interaction:
  • Chains: C-D
  • Int. Res.: 67
  • Norm. En. per Res.: -5.4063
• Hub Node: A(2)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-66.101	-62.0861	-124.079	-252.2661	66	26	0	6156	16	59	57
A-C	0.0	5.8968	-2.4255	3.4714	9	0	0	146	0	7	6
C-D	-80.5359	-149.26	-132.426	-362.2219	67	27	0	6143	20	58	56

Interface residues

• A-B: ALA36B, ALA45B, ARG44B, ARG48A, ASN40B, ASN81B, ASN92A, ASP31A, ASP32A, ASP33B, ASP40A, ASP84B, ASP87A, GLN31B, GLN46A, GLU25B, GLU36A, GLU37B, GLU39B, GLU42B, GLU50A, GLU52A, GLU76B, GLU78B, GLU95A, GLY90A, ILE33A, ILE82B, ILE85A, ILE97A, LEU27B, LEU38B, LEU94A, LYS29B, LYS30B, LYS32B, LYS34A, LYS34B, LYS41A, LYS42A, LYS43A, LYS49A, LYS50B, LYS51A, LYS82A, LYS89A, LYS91A, LYS96A, MET77B, MET86B, PHE43B, PHE46B, PHE49B, PHE54A, PRO80B, SER41B, SER47B, SER48B, SER79B, SER84A, SER85B, THR83B, THR88A, TYR86A, VAL35B, VAL93A
• A-C: ARG105C, GLN103C, GLU104A, GLU104C, GLU8A, GLU8C, LYS101A, TRP10A, TRP10C
• C-D: ALA36D, ALA45D, ARG44D, ARG48C, ASN40D, ASN81D, ASN92C, ASP31C, ASP32C, ASP33D, ASP40C, ASP84D, ASP87C, GLN31D, GLN46C, GLU25D, GLU36C, GLU37D, GLU39D, GLU42D, GLU50C, GLU52C, GLU76D, GLU78D, GLU95C, GLY90C, ILE33C, ILE82D, ILE85C, ILE97C, LEU27D, LEU38D, LEU94C, LYS29D, LYS30D, LYS32D, LYS34C, LYS34D, LYS41C, LYS42C, LYS43C, LYS49C, LYS50D, LYS51C, LYS82C, LYS89C, LYS91C, LYS96C, PHE43D, PHE46D, PHE49D, PHE54C, PRO80D, SER39C, SER41D, SER47D, SER48D, SER79D, SER84C, SER85D, THR38C, THR83D, THR88C, TYR86C, VAL26D, VAL35D, VAL93C